索引于
  • 学术期刊数据库
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 中国知网(CNKI)
  • 西马戈
  • 访问全球在线农业研究 (AGORA)
  • 电子期刊图书馆
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Rhodobacter sphaeroides Extract Improves Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice

Chih-Chiang Wang, Wen-Sheng Liu, Fu-Hsin Chang, Pei-Yi Tsai, Ming-Kai Tsai, Jeng-Chuan Shiang and Zhi-Hong Wen

Insulin resistance is one of the most important mechanisms of diabetes mellitus. Anti-oxidants had been proved to improve insulin resistance. However, the direct relation between anti-oxidants and glucose homeostasis is still elusive. Recently, we found that LycogenTM (extracts of Rhodobacter sphaeroides WL-APD911) has lycopene-like activity. Furthermore, LycogenTM showed more potent anti-oxidative effect and less cytotoxicity than lycopene. To evaluate the effect of LycogenTM on blood glucose levels, STZ-induced diabetic mice were randomly divided into four groups: (1) diabetes control group; (2) diabetes+LycogenTM 50 mg/kg; (3) diabetes+LycogenTM 100 mg/kg; and (4) diabetes+LycogenTM 200 mg/kg. After 7 days of treatment, the blood glucose level in the LycogenTM 200 mg/kg group was significantly lower than the disease control group (p<0.01). In the oral glucose tolerance test, the blood glucose level was significantly lower in the LycogenTM 200 mg/kg group than the disease control group (p<0.05). Our results confirmed that LycogenTM, a potent anti-oxidant, can significantly lower blood glucose levels in a diabetic mice model.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证